Philips Future Health Index 2025: AI poised to transform global healthcare, urging leaders to act now

• 46% fear missed opportunities for early diagnosis and intervention
• 46% cite growing burnout from non-clinical tasks
• 42% worry about an expanding patient backlog

Trust gaps remain the biggest barrier to widespread AI adoption
While clinicians are generally optimistic, the FHI 2025 report highlights a significant trust gap with patients – 34% more clinicians see AI’s benefits than patients do, with optimism especially lower among patients aged 45 and older. Even among clinicians, skepticism remains: 69% are involved in AI and digital technology development, but only 38% believe these tools meet real-world needs. Concerns around accountability persist, with over 75% unclear about liability for AI-driven errors. Data bias is another major worry, as it risks deepening healthcare disparities if left unaddressed. “To build trust with clinicians, we need education, transparency in decision-making, rigorous validation of models, and the involvement of healthcare professionals in every step of the process,” Brown added. 

The path forward: human-centric AI integration
Patients want AI to work safely and effectively, reducing errors, improving outcomes, and enabling more personalized, compassionate care. Clinicians say trust hinges on clear legal and ethical standards, strong scientific validation, and continuous oversight. As AI reshapes healthcare, building trust is essential to delivering life-saving innovation faster and at scale.

“To realize the full potential of AI, regulatory frameworks must evolve to balance rapid innovation with robust safeguards to ensure patient safety and foster trust among clinicians,” said Shez Partovi, Chief Innovation Officer at Philips. “By 2030, AI could transform healthcare by automating administrative tasks, potentially doubling patient capacity as AI agents assist, learn, and adapt alongside clinicians. To that end, we must design AI with people at the center—built in collaboration with clinicians, focused on safety, fairness, and representation—to earn trust and deliver real impact in patient care.”

About the Future Health Index 2025
The Future Health Index is the largest global survey of its kind, analyzing the priorities and perspectives of healthcare professionals and patients across multiple countries. The Future Health Index 2025 investigates how innovative technologies, particularly AI, can empower healthcare professionals to deliver better care to more people. For more information, or to download the full FHI 2025 Global Report, visit www.philips.com/futurehealthindex-2025.

For further information, please contact:

Kathy O’Reilly
Philips Global External Relations
Tel.: +1 978-807-1449
E-mail: kathy.oreilly@philips.com

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people’s health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home.

Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2024 sales of EUR 18 billion and employs approximately 67,200 employees with sales and services in more than 100 countries. News about Philips can be found at www.philips.com/newscenter.

Attachments

• FHI 2025 Global Report Infographic
• Family members
• A healthcare professional and their patient in discussion